A live -attenuated pneumococcal vaccine-based therapy for lowering cholesterol, and triglycerides levels: Repurposing the live -attenuated pneumococcal vaccine into a cholesterol-lowering vaccine that inhibits Non-alcoholic fatty liver disease (NAFLD): Live -attenuated pneumococcal vaccine decreases the levels of HMGCR,  triglycerides, free cholesterol, and total cholesterol and prevents the progression of Non-alcoholic fatty liver disease (NAFLD, via down-regulation of its target gene, 12/September/2018, 11.58 pm